The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

Abstract Background At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the MDR-TB treatment landscape. However, despite their avail...

Descripció completa

Dades bibliogràfiques

Autors principals:	Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan, Kwonjune J. Seung
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2019-08-01
Col·lecció:	BMC Infectious Diseases
Matèries:	MDR-TB Bedaquiline Delamanid Safety Efficacy
Accés en línia:	http://link.springer.com/article/10.1186/s12879-019-4378-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!